Paolo Tarantino
@ptarantinomd
MD, PhD, Medical Oncologist | Clinical Fellow @DanaFarber | @Harvard. SoMe Editor @ESMO_Open. Interested in breast oncology, HER2, ADCs and good music.
ID: 958742483856486400
31-01-2018 16:43:15
13,13K Tweet
26,26K Followers
651 Following
The DAISY trial of T-DXd in MBC with variable HER2 expression is out on Nature Medicine. Many important findings, including a similar ORR with T-DXd in HER2-low (37.5%) & HER2-0 (29.7%) MBC. Congrats to Fernanda Mosele FabriceAndre et al for this impressive work! nature.com/articles/s4159…
